SCHEMBL3388700

SCHEMBL3388700

COc1cccc(-c2cccc(CO)c2Br)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
PDCD1 Q15116 3/20 0.44
CD274 Q9NZQ7 3/20 0.44
LMNA P02545 2/20 0.43
ALDH1A1 P00352 1/20 0.43
HTR7 P34969 1/20 0.43
BRD4 O60885 1/20 0.43
CDK4 P11802 1/20 0.42
CCND1 P24385 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
ADORA2A P29274 1/20 0.41
CYP1A1 P04798 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2E1 P05181 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5885855 0.82 TSHR (0.51) MAPK1TSHRHSD17B10PDCD1CD274
SCHEMBL25423383 0.79 MAOB (0.48) PDCD1CD274CYP1A1CYP1A2CYP2B6
SCHEMBL10982314 0.78 PDCD1 (0.60) MAPK1HSD17B10PDCD1CD274ALDH1A1
SCHEMBL30625954 0.78 PDCD1 (0.60) MAPK1HSD17B10PDCD1CD274ALDH1A1
SCHEMBL17295958 0.77 ABCB1 (0.52) MAPK1TSHRHSD17B10PDCD1CD274
SCHEMBL28854331 0.76 HTR7 (0.51) MAPK1TSHRLMNAALDH1A1HTR7
SCHEMBL28679880 0.76 CYP1A1 (0.45) LMNAALDH1A1HTR7BRD4HDAC4
SCHEMBL3455245 0.75 ABL1 (0.60) MAPK1LMNAALDH1A1BRD4ADORA2A
SCHEMBL2020140 0.74 ABL1 (0.59) LMNAALDH1A1BRD4HDAC4HDAC8
SCHEMBL30728873 0.74 HTR7 (0.43) MAPK1TSHRCD274LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010023317-A1 NOVEL HEXAFLUORO-2-BIPHENYLISOPROPANOL COMPOUNDS THAT MODULATE LXR-TYPE RECEPTORS, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF AS MEDICAMENTS IN HUMAN AND VETERINARY MEDICINE AND ALSO IN COSMETICS GALDERMA RESEARCH & DEVELOPMENT (FR) 2010-03-04 WO disclosed